Chevy Chase Trust Holdings LLC Sells 3,859 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Chevy Chase Trust Holdings LLC lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.5% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 105,867 shares of the company’s stock after selling 3,859 shares during the quarter. Chevy Chase Trust Holdings LLC’s holdings in HCA Healthcare were worth $34,013,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in HCA. Atlantic Edge Private Wealth Management LLC bought a new position in HCA Healthcare during the fourth quarter valued at about $27,000. Bangor Savings Bank lifted its holdings in HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC lifted its holdings in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. LifeSteps Financial Inc. purchased a new stake in HCA Healthcare during the first quarter valued at about $33,000. Finally, Rise Advisors LLC purchased a new stake in HCA Healthcare during the first quarter valued at about $36,000. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of a number of recent analyst reports. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Monday. Barclays increased their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft increased their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday, June 28th. Finally, Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Four research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $354.67.

Insider Activity

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,844 shares of company stock worth $3,185,932. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Stock Up 1.0 %

Shares of HCA traded up $3.59 during trading hours on Wednesday, hitting $378.90. The company had a trading volume of 271,225 shares, compared to its average volume of 1,136,239. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $379.52. The firm has a fifty day moving average price of $341.89 and a 200-day moving average price of $329.44. The stock has a market capitalization of $99.24 billion, a price-to-earnings ratio of 18.71, a P/E/G ratio of 1.39 and a beta of 1.68. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the firm earned $4.29 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.70%. HCA Healthcare’s payout ratio is currently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.